0001691194-16-000001.txt : 20161205 0001691194-16-000001.hdr.sgml : 20161205 20161205163540 ACCESSION NUMBER: 0001691194-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161205 DATE AS OF CHANGE: 20161205 EFFECTIVENESS DATE: 20161205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trieza Therapeutics, Inc. CENTRAL INDEX KEY: 0001691194 IRS NUMBER: 814444483 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-275660 FILM NUMBER: 162034203 BUSINESS ADDRESS: STREET 1: C/O POTENZA THERAPEUTICS, INC. STREET 2: 1030 MASSACHUSETTS AVENUE, SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-588-4150 MAIL ADDRESS: STREET 1: C/O POTENZA THERAPEUTICS, INC. STREET 2: 1030 MASSACHUSETTS AVENUE, SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0707 D LIVE 0001691194 Trieza Therapeutics, Inc. 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA MASSACHUSETTS 02138 617-588-4150 DELAWARE None None Corporation true 2016 Daniel Hicklin 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director David Cordo 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Luke Evnin 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Pharmaceuticals Decline to Disclose 06b false 2016-11-21 false true false 0 1 1 0 The Company issued shares of its capital stock to Potenza Therapeutics, Inc. ("Potenza"), its former parent company, which distributed the shares as a dividend to certain Potenza shareholders in connection with the spin-out of the Company from Potenza. false 5 0 0 0 false Trieza Therapeutics, Inc. /s/ Daniel Hicklin Daniel Hicklin President 2016-12-02